Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cisplatin vs Paclitaxel for Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Lurbinectedin (PM01183) in Combination With Cisplatin in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Two Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Non-comparative Study of Treatment With Induction Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation or Definitive Chemoradiation in Invasive Locally Advanced Carcinomas of Uterine Cervix.
- Status
- UNKNOWN
- Phase
- PHASE2
Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.
- Status
- COMPLETED
- Phase
- PHASE3
Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 Study
- Status
- TERMINATED
- Phase
- PHASE1
Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
(PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm.
- Status
- COMPLETED
- Phase
- PHASE1
Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)
- Status
- COMPLETED
- Phase
- PHASE1